We describe our efforts to crystallize binary MCM1/DNA and ternary MATa2/MCM1/DNA complexes, including the unsuccessful attempts to crystallize MCM1/DNA complexes and the successful design of DNA crystal packing that resulted in high-resolution crystals of the MATa2/ MCM1/DNA complex. We detail general procedures useful for preparing protein/DNA cocrystals, including improved methods for producing and purifying DNA-binding proteins and DNA fragments, for purifying protein/DNA complexes, and for controlling pH conditions during crystallization. We also describe the rational design of DNA for protein/DNA cocrystallization attempts, based on our analysis of how straight and bent DNA with single base-pair overhangs can pack end-to-end in a crystal.
Introduction
Our understanding of the molecular interactions between DNA-binding proteins and DNA has bene®tted greatly from X-ray and NMR structure determination of protein/DNA complexes and the resulting detailed views of the interaction surfaces. X-ray crystallography is the method of choice for protein/DNA complexes with molecular masses of greater than 30 kDa, but crystallizing the complex remains the rate-limiting step for many structural determinations. The dif®culty of obtaining diffraction-quality macromolecular crystals can usually be traced to the need for large quantities of highpurity material and the empirical nature of crystallization. For protein/DNA cocrystals, both protein and DNA components must be overexpressed or synthesized, and the resulting protein/DNA complex then characterized and puri®ed. Optimization of each of these steps is often required to produce high-resolution protein/DNA crystals.
The precise choice of DNA fragments can be critical to the formation of protein/DNA cocrystals because interactions between DNA molecules often generate crystal packing contacts. The two predominant strategies for selecting DNA fragments are the empirical searches for fragments of different lengths and ends (Anderson et al., 1984) , and the rational design of DNA fragments that pack in de®ned ways in the crystal (Jordan et al., 1985) . In many of the protein/DNA cocrystals solved to date, the DNA packs end-to-end as a pseudocontinuous helix. Anderson et al. (1984) noted that DNA fragments which pack end-to-end to match the helical repeat of DNA would be appropriate choices for cocrystallization attempts. Thus, a 21 bp DNA fragment with two turns of a 10.5 bp/ turn helix would be a likely candidate under this scheme, as would a 14 bp DNA fragment that, when repeated three times, produces 42 bp or four turns of a 10.5 bp/turn helix. In fact, of the 32 protein/DNA complexes in the RCSB Protein Data Bank containing DNA lengths of 20 or 21 bp as of November 1999, all but one contained zero, one or two complementary overhanging bases at the two ends, and 28 of these produced pseudocontinuous DNA helices through the crystal via these complementary ends.
Most protein/DNA cocrystallization attempts therefore involve screening different DNA substrates, a process greatly helped by the relative ease of synthesizing and purifying milligram quantities of oligonucleotides. However, synthetic oligonucleotides are limited to sizes of 30 bases or less for the preparative-scale synthesis yields and purity needed for structural work. For this reason, at least three protein/DNA structures (CAP/DNA, gd-resolvase/DNA and IHF/DNA) have used overlapping complementary oligonucleotides to create longer, nicked DNA fragments for crystallization (Rice et al., 1996; Schultz et al., 1990; Yang & Steitz, 1995) . An alternative method to produce large quantities of crystallization-quality DNA is the isolation of restriction fragments from plasmids grown in Escherichia coli, as pioneered in studies of the nucleosome (Richmond et al., 1988) . A signi®-cant advantage of using restriction fragments is the ability to isolate homogeneous DNA fragments without size limitations, an important consideration for crystallizing binary or higher order complexes containing large DNA binding sites. However, it is usually necessary to construct plasmids with multiple copies of the desired insert to obtain the milligram quantities required for crystallization, and each insert in such a plasmid must be in the same orientation to avoid unstable palindromic sequences (Gupta et al., 1983) .
Here, we detail the steps taken to produce highresolution crystals of a ternary complex of the yeast transcription factors MCM1 and MATa2 (abbreviation, a2) bound to DNA, a complex required for the repression of mating type genes. The structure of this complex has been described elsewhere (Tan & Richmond, 1998) . Our unsuccessful attempts to crystallize binary MCM1/DNA complexes and full-length a2/MCM1/DNA complexes led to a directed strategy where we optimized both protein and DNA fragments for crystallization. Our work also involved improving protein puri®cation methods, and developing schemes for producing large quantities of de®ned sequence DNA fragments in E. coli. In addition, we present a general framework for the rational design of DNA fragments lengths and ends to guide future protein/DNA cocrystallization attempts.
Results
Improved use of heparin-Sepharose to purify DNA-binding proteins
We and others have found that many DNAbinding proteins can be puri®ed from an E. coli crude extract using heparin-Sepharose. The crude extract prepared by lysis of the overexpressing cells and clari®cation by centrifugation can be loaded onto the resin without prior removal of nucleic acid by protamine sulfate or polyethyleneimine. One novel step we have added is washing with buffer containing moderate concentrations of urea in addition to salt washes. We reasoned that many of the contaminants eluting with the desired protein were binding non-speci®cally via hydrophobic interactions to the resin, or proteins bound to the resin. Reducing this hydrophobic interaction with urea at concentrations insuf®cient to denature the desired protein (2 to 3 M) removes many contaminating proteins. Figure 1 shows that signi®cant amounts of contaminating protein can be eluted with buffer containing 3 M urea with only moderate losses of the desired MCM1(1-100), resulting in purer protein eluting from the column during the gradient elution.
Isolation of STE2 35mer operator DNA
We created plasmids that contain multiple tandem copies of a STE2 35mer, each arranged in a head-to-tail orientation to reduce stability problems encountered with palindromic repeats. Our attempts to create a plasmid with multiple inserts by directly subcloning a synthesized DNA fragment self-ligated in a ®xed orientation produced a maximum of four inserts in a plasmid. We have therefore implemented a procedure, which was suggested by Richmond et al. (1988) , to successively double the number of tandem inserts in a plasmid. This procedure relies on a pair of restriction enzymes which produce compatible ends (SalI and XhoI in this case). The insert was subcloned into a plasmid vector such that it was¯anked by SalI and XhoI sites. As shown in Figure 2 (a), isolation of the appropriate vector fragment (EcoRI-SalI) and insert fragment (EcoRI-XhoI) and subsequent ligation results in the doubling of the insert with a short linker in between. When ligated, the compatible ends of the SalI/XhoI pair produce a site that is recognized by neither restriction enzyme. Thus, the insert resulting from the doubling procedure is once again¯anked by unique SalI and XhoI sites, and is suitable for additional rounds of doubling. Other pairs of restriction enzymes producing compatible ends can be used, such as BamHI and BglII, with the only restriction that neither the insert nor the vector fragments contain such sites. We have used this doubling procedure to produce pST17, a plasmid with 48 copies of a 35 bp fragment containing the nearly symmetric STE2 31 bp UAS element (Figure 2(b) ) as well as pST5, a plasmid containing 40 copies of an 84 bp fragment used to produce symmetric 146 bp DNA fragments for studies of the nucleosome core particle (Flaus et al., 1996) . A similar procedure for generating recombinant nucleosomal DNA, which substitutes less-ef®cient blunt end ligation for our compatible-end cloning strategy, has been described .
The 35mer insert in the pST17 plasmid was released with EcoRV digestion and puri®ed from the 2700 bp vector fragment and the 11 bp linker (which includes the destroyed SalI/XhoI site) by a combination of PEG precipitation and anion-exchange HPLC (Figure 3) . We routinely obtain 100 to 120 mg of pST13 plasmid from 12 l of HB101/pST13, which yields 20 to 25 mg of puri®ed STE2 35mer. Although the pST17 plasmid contains twice as many STE2 35mer inserts as pST13, we obtained similar quantities of insert from SURE/pST17 as from HB101/pST13 because of the reduced yield of plasmid from the SURE strain.
Crystallization of MCM1/DNA complexes
Despite multiple attempts, we were unable to crystallize full-length MCM1 alone or complexed with DNA. DNA fragments tested for the cocrystallization studies were the STE2 35mer, and symmetric P-box oligonucleotides of length 16, 17 and 18 bases (STO85, respectively) . Since the C-terminal two-thirds of MCM1 contains an unusual sequence composition, further crystallization trials were directed at the MCM1(1-100) deletion, which is suf®cient for DNA-binding in vitro and mating-type function in vivo (Bruhn et al., 1992; Christ & Tye, 1991; Primig et al., 1991) . We examined 85 different DNA fragments in three sequence categories: symmetric P-box sequences, a-speci®c sequences such as STE2 UAS elements, and a-speci®c sequences such as STE3 UAS elements (Table 1 ). Furthermore, we incorporated different ends on the DNA fragments to encourage end-toend or other packing of DNA in the crystal. In addition to blunt ends, single base-pairs overhangs were included to allow Watson-Crick base-pairing or triple strand formation. Only small crystals unsuitable for diffraction studies were obtained with MCM1(1-100)/P-box complexes, whereas no crystals were obtained for MCM1(1-100)/STE2 UAS complexes.
Attempts to crystallize MCM1(1-100)/STE3 complexes met with limited success. All the MCM(1-100) cocrystals that we obtained contained variants of a STE3 UAS 18 bp fragment. MCM1(1-100)/ (STO60/61) blunt end DNA cocrystals diffract to about 10 A Ê , with characteristic streaky spots. When single-base overhangs are added compatible with triple strand formation at the ends (e.g. STO138/139), the resulting crystals diffracted to about 8 A Ê without the streaky spots observed with blunt ended DNA cocrystals. Considerable effort was needed to acquire MCM1(1-100) crystals of suf®cient size for diffraction studies, since showers of small crystals were initially obtained. The two successful modi®cations were preparative electrophoresis to purify the protein/DNA complex and use of a slow pH gradient during crystallization.
Our experiments show that preparative electrophoresis puri®ed MCM1(1-100)/(STO138/139) produces larger crystals by reducing the number of nucleation events, presumably by removing aggregates that might be formed by excess protein.
Attempts to control nucleation with microseeding were not successful. Since many DNA-binding proteins are positively charged overall, and since pro- Figure 1 . Heparin-Sepharose puri®cation of MCM1(1-100) and use of a moderate concentration urea wash to remove non-speci®cally bound proteins. (a) UV absorption trace of eluent from heparin-Sepharose column monitored at 276 nm. Both NaCl washes contained 300 mM NaCl, while the urea wash contained an additional 3 M urea. The remaining protein was eluted with a linear gradient from 300 mM to 1500 mM NaCl. Washing and elution steps are indicated above the trace, while pooled samples are indicated below (FT,¯ow-through) . (b) Coomassie-stained SDS-PAGE gel of heparin-Sepharose fractions. The urea wash contains signi®cant amounts of contaminating proteins that would otherwise elute during the gradient elution (data not shown). Note that the gradient elution pool was also passed through a Matrex Blue A column which removes additional contaminants. Positions of molecular mass markers are indicated on the left. H with compatible ends to each other, can be duplicated in a plasmid. This doubling procedure can be reiterated to further increase the number of insets in the plasmid, since each plasmid will contain a unique B and B H site. Four rounds of the doubling procedure were used to increase the insert copy number of six in pST11, to 48 copies in pST17. (b) Schematic plasmid containing 48 copies of STE2 35mer. The arrangement of inserts in the plasmid shows that tandem blocks of six contiguous repeats are separated by an 11 bp linker, which contains the two half-sites for EcoRV as well as the sequence CTCGAG which results from the ligation of SalI and XhoI ends. Sequences for the STE2 35mer and the 11 bp linker are presented, with the EcoRV sites underlined. tein/DNA complexes often migrate signi®cantly slower then DNA alone, puri®cation of the protein/DNA complex from excess DNA or protein is usually easy to achieve, requiring little optimization beyond the concentration of acrylamide in the gel. The preparative electrophoresis system that we used offers a further bene®t that the elution buffer can be different from the electrophoresis buffer, enabling the sample to be concentrated immediately without additional dialysis. We also used preparative electrophoresis to purify the homologous SRF/DNA complex prior to crystallization and subsequent structure determination (Pellegrini et al., 1995) . Other examples of preparative electrophoresis to complexes prior to crystallization include the interferon g/interferon g receptor complex (Fountoulakis et al., 1993 ) and the nucleosome core particle Luger et al., 1997a,b) . Our observation that the MCM1(1-100)(STO138/ 139) crystals were sensitive to variations of 0.1 pH unit prompted us to use a volatile buffer such as acetate to change the pH of the crystallization drop over several days. This acute sensitivity to pH conditions, which was also observed during crystallization of the glucocorticoid receptor/DNA complex (B. Luisi, personal communication), may re¯ect the requirement of a protonated cytosine base to form the Hoogstein base-pairing at the triple strand end. The use of a pH gradient during crystallization signi®cantly increased the reproducibility of growing suitably large crystals, probably because the pH gradient allows a range of pH to be sampled during crystallization. This increases the chance of the sample encountering the appropriate conditions for nucleation and/or growth as compared to a discrete set of pH conditions. The pH in the hanging drop will gradually approach the pH of the reservoir, with the time required for the change determined predominantly by the volatility and concentration of the volatile buffer, and the temperature of the system.
We also tried to improve the diffraction of the MCM1/DNA cocrystals by modifying both the protein and DNA components. The two MCM1 deletions examined were MCM1(1-96) and MCM1(16-98). MCM1(1-96) produced similar cocrystals with STO138/139 to MCM1(1-100) under the same crystallization conditions, whereas MCM1(16-98) required different conditions for cocrystal formation. However, no improvement in diffraction quality was observed with these polypeptide deletion variants. Varying the DNA length eliminated crystal formation, although changes in DNA sequence could be tolerated and cocrystals were obtained using other a-speci®c sequences such as MFa1B. Despite these and other changes such as different triple strand ends (Table 1) and use of 5 H phosphorylated oligonucleotides (data not shown), only similar or worse diffraction quality was obtained as compared to the MCM1(1-100)/ STO138/139 crystals.
Crystallization of a a a2/MCM1/DNA complexes
We attempted crystallization of full-length a2 in a ternary complex with several MCM1 deletions and the recombinant STE2 35mer. Each of these ternary complexes containing full-length MCM1, MCM1(1-166), MCM1(1-100) or MCM1(16-98) was puri®ed by gel-®ltration chromatography prior to crystallization trials (data not shown). However, these crystallization trials did not produce any crystals, despite the use of different precipitating agents under a variety of conditions.
Our unsuccessful attempts to obtain diffractionquality crystals of MCM1/DNA or full-length a2/MCM1/DNA complexes led us to develop a rational design to crystallize a complex containing a2, MCM1 and DNA. Since we were most interested in characterizing those interactions responsible for formation of the a2/MCM1/DNA ternary complex, we decided to eliminate polypeptide segments not required for this interaction, but we retained segments if they contributed to stability or Type indicates the sequence (respective promoter or P-box consensus sequence).
The length of each of the two strands that comprise the cocrystallization DNA is given in the size column. The type of DNA ends is indicated as WC for Watson-Crick overhang, C $ GC for C $ GC triple strand overhang, T $ AT for T $ AT triple strand overhang, 5
H N for single N base overhang or blunt. The expected direction of the cocrystallization DNA if packed end to end is provided as 33 if adjacent DNA fragments pack head-to-tail, 32 if they pack head-to-head and 6 if they can pack in either direction.
Results of crystallization trials of MCM1 (1-100)/DNA complexes are provided in the MCM1(1-100) xtals column. A dash indicates that no crystals were observed. The highest resolution for which diffraction was detected is presented in the diffraction column. Protein/DNA Cocrystallization Strategies solubility. We therefore selected MCM1(1-100), since it contains the conserved DNA-binding domain that is suf®cient for interaction with a2, as well as the ®rst 18 amino acid residues that improve solubility of the polypeptide (unpublished results). The a2(103-189) polypeptide selected eliminates the N-terminal domain as well as the short C-terminal tail responsible for interaction with MATa1, but retains the homeodomain and the N-terminal extension that is required and suf®cient for interaction with MCM1 (Vershon & Johnson, 1993 ). Since we anticipated that MCM1 would bend DNA (based on the strong homology to SRF, our structure of the SRF/DNA complex (Pellegrini et al., 1995) and circular permutation studies (Acton et al., 1997)), we chose DNA fragments that could pack end-to-end in a crystal whether or not the DNA was bent. This was achieved by using DNA lengths equivalent to half-integral repeat of the DNA helix pitch (25-27 bp) and by incorporating appropriate DNA ends to allow end-to-end packing. Use of a 25-27 bp DNA fragment precludes two a2 binding sites¯anking the central MCM1 site found in a-speci®c UAS elements. However, since we ®nd that a2(103-189) does not bind cooperatively to the STE2 35mer (data not shown), we chose to use a truncated UAS element containing only one a2 binding site (Figure 4) . We obtained ternary complex crystals for ®ve of the ten DNA fragments examined (all produced by phosphoramidite chemical synthesis), including a STE6 26mer (STO577/578), for which the ternary complex crystal diffracts to 2.25 A Ê . a2(103-189)/ MCM1(1-100)/(STO577/578) crystallizes in space group P2 1 2 1 2 1 with cell dimensions 70.6 A Ê Â 72.6 A Ê Â 150.7 A Ê , where the longest dimension is consistent with a bent 26 bp DNA fragment packed end-to-end along this long axis.
Discussion and Conclusion
Our success at crystallization of the ternary a2/ MCM1/DNA complex was dependent on selecting the right protein and DNA components. Regions of MCM1 and a2 that were not involved in the formation of the ternary complex were eliminated, although we did retain the N-terminal 17 amino acids residues of MCM1 that increased the solubility of the protein. By removing polypeptide segments not involved in the function we were interested in investigating, we reduced the likelihood of unstructured regions which could interfere with crystallization contacts.
Our choice of cocrystallization DNA fragment was based on an analysis of how DNA can pack in a crystal. Previous analyses of possible DNA crystal packing arrangements for protein/DNA complexes were limited to straight DNA with WatsonCrick base-pairing ends. We wish to extend this crystal packing analysis to include bent DNA and the use of triple strand ends. As shown in Figure 5 (a), the integral repeat DNA packing by Anderson et al. (1984) applies when the DNA helix is not distorted by intrinsic or protein-induced bending. An integral repeat of bent DNA will form a superhelix when packed end-to-end ( Figure 5(b) ), as was observed in the a1/a2/DNA P6 1 cocrystal with six 21mer monomers in each superhelical repeat (Li et al., 1995b) . However, crystals containing one superhelical repeat and reasonable unit cell dimensions require an integral number of DNA monomers per superhelical turn, which constrains the DNA bend angle to discrete values. In fact, the 60 DNA bend angle in the al/a2/DNA crystal structure is less than the 100 bending estimated by solution methods (Jin et al., 1995; Li et al., 1995a; Smith et al., 1995) . Conversely, it is possible that the integral repeat DNA packing in many of the other protein/DNA crystals may have favored relatively straight DNA. Such arti®cial constraints on the structure of DNA in a protein/DNA crystal can be avoided if a half-integral repeat of DNA such as 16 or 26 bp is used (assuming a B-form conformation), since the DNA can then pack endto-end in a zig-zag fashion to produce a 2 1 screw axis. In this scheme, no restrictions are placed on the DNA bend angle, since any bend in one DNA Figure 4 . Sequence of STE6 operator and synthetic DNA fragment successfully used to crystallize a2/MCM1/DNA complex. The 31 bp STE6 operator with¯anking sequence is shown with the location of the locations of the consensus P-box MCM1 binding site and the¯anking a2 major groove binding sites. The sequences of the two synthetic oligonucleotides, STO577 and STO578, are provided below, while the sequence of the STE2 35mer is provided above for comparison. monomer is compensated by the next monomer ( Figure 5(c) ).
Although Watson-Crick hydrogen bonds for promoting end-to-end packing of DNA have been heavily used in protein/DNA cocrystals, triple strand base-pairings provide an important alternative. The glucocorticoid receptor/DNA (Luisi et al., 1991) , SRF/DNA (Pellegrini et al., 1995) and CAP/ DNA (Schultz et al., 1990) complexes showed that C or G can form a triple strand in the major groove of a G ÁC base-pair for an alternate end-to-end packing ( Figure 5(d)-(i) ). Both the C -GC (Hoogstein interactions, also true for A-TA) and G-GC ends result in a disjointed DNA helix as compared to the continuous helix with Watson-Crick ends (Figure 5(f) and (g) ). The disjointed helix with C -GC triple strand ends involves an angular displacement equivalent to backing up the helix by 2 bp in addition to a translational displacement (Figure 5(g) and (i) ). Thus the effective DNA helical twist repeat for DNA fragments forming C -GC (or A-TA) triple strands ends is 2 bp less than the actual repeat length. Both the glucocorticoid receptor/DNA and SRF/DNA complexes used 18 bp DNA fragments with a single base overhang. This corresponds to an effective DNA helical twist repeat of 16 bp, which is a half-integral helical twist repeat appropriate for structures with both straight (glucocorticoid/DNA) and bent (SRF/DNA) DNA (Figure 5(e) ). Similarly, a halfintegral helical twist of DNA was also present in the CAP/bent DNA structure which used the equivalent of a 30 bp fragment with single base overhangs. The disjointed helix in the CAP/DNA structure with the G-GC triple strand ends backs up the helix by 3 bp, so that the 30 bp DNA repeat corresponds to a 27 bp effective helical twist repeat or approximately 2.5 helical repeats ( Figure 5(d) , (f) and (h)).
The major bene®t of triple-stranded ends is to increase the range of DNA lengths compatible with end-to-end packing in a crystal. Furthermore, the distance between the binding sites increases by 2 bp for C -GC and G-GC triple strand ends compared to Watson-Crick base-pairing ends. For example, the repeat length of the 19mer with C -GC ends used in the SRF/DNA complex is 18 bp, since the triple strand base-pairings at each end result in the net loss of 1 bp of repeat length. As described above, this corresponds to a 16 bp helix repeat length or one and a half turns of the DNA helix. In contrast, the equivalent DNA fragment using Watson-Crick base-pairing would be a 16mer with complementary overhanging ends. Such a fragment would possess both 16 bp repeat length, as well as 16 bp helical twist repeat. This additional 2 bp spacing of repeat length afforded by the triple-stranded ends (as compared to the Watson-Crick ends) might be useful, since it reduces the possibility of steric hindrance between protein components on adjacent DNA fragments. An ef®cient strategy for protein/DNA cocrystallization is to vary both DNA length, to allow for DNA helical repeats other than B-form 10.5 bp/turn, as well as DNA ends, to accommodate Watson-Crick or triple-stranded base-pairing ends. The ability to vary such parameters is likely to increase the variety of crystal packing possible and therefore the likelihood of obtaining crystals.
We have used these improved methods for protein and DNA expression and puri®cation, design of protein/DNA complexes and crystallization to produce high-resolution a2/MCM1/DNA ternary complex crystals. These crystals have allowed us to determine the structure of the complex at 2.25 A Ê , which explains how a2 and MCM1 bind cooperatively to DNA, as well as documenting an unusual structural¯exibility of a2 (Tan & Richmond, 1998 ). The structure also shows that the DNA in the crystal does pack in a zig-zag manner as predicted ( Figure 5(c) ). However, this designed crystal packing in one dimension was accompanied by other fortuitous crystal packing, including the incorporation of a second copy of a2 which provides perpendicular packing interactions by bridging between adjacent complexes in the crystal (see Figure 1 (c) by Tan & Richmond, 1998) . Thus, our designed DNA crystal contacts may have improved the chances of obtaining crystals, but we are still unable to predict or design all crystal interactions.
Materials and Methods
Overexpression and purification of MCM1(1-100) MCM1(1-100) was overexpressed using a pET3a-based expression plasmid containing the entire MCM1 coding region and a TAA stop codon inserted after MCM1 codon 100. BL21(DE3)pLyS cells containing the pET3a-MCM1(1-100) plasmid were induced at 27-29 C with 0.2 to 0.4 mM IPTG and harvested after 10-15 hours incubation at the same temperature.
Cells from 6 l of culture overproducing MCM1(1-100) were resuspended in 150 ml of T300 (20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 0.5 mM EDTA, 1 mM benzamidine, 10 mM 2-mercaptoethanol), lysed by freeze-thawing and homogenized using an Ultra-Turrax blender device to reduce the viscosity of the cell extract. A cleared extract was prepared by centrifuging the crude extract at 40,000 g and re-extraction of the pellet with an additional 100 ml of T300 buffer. The cleared extract was applied by continuous¯ow to a 2.5 cm internal diameter Â 8 cm (40 ml) heparin-Sepharose column for 12-16 hours to ensure ef®cient binding of MCM1 to the resin. The column was then washed with 100 ml of T300, 150 ml of TU300 (3 M urea) (T300 with 3 M urea), 100 ml of T300 and eluted with a linear gradient of 50 ml of T300 50 ml of T1500. Flow from the heparinSepharose column was directed to a 10 ml Matrex Blue A (Amicon) column equilibrated in T300 when the single large peak was detected. The Matrex Blue A¯ow-through fractions were pooled, dialyzed against 1 mM Hepes (pH 7.5), 300 mM NaCl, 5 mM 2-mercaptoethanol and further puri®ed over a 21.5 mm internal diameter Â 150 mm TSK SP-5PW HPLC column at pH 7.5 (linear gradient from 25O mM to 1000 mM NaCl). The SP-5PW pool was then dialyzed against 1 mM Hepes (pH 7.5), 300 mM NaNO 3 , 0.5 mM DTT and concen- Figure 5 trated by ultra®ltration to 50-100 mg/ml. Yields varied between 100 and 250 mg from 6 l of cells. Protein concentrations were calculated using the theoretical extinction coef®cient of 0.12 (mg/ml) À1 cm À1 (Gill & von Hippel, 1989) .
Overexpression and purification of a a a2(103-189)
The a2(103-189) gene fragment was subcloned into the pRET3a expression vector (S.T. and T.J.R., unpublished data), a pET3a derivative which expresses the ArgU gene to overcome potentially limiting amounts of tRNA Arg AGA,AGG in E. coli. The a2(103-189) gene fragment was overexpressed in BL21(DE3)pLysS cells after two hours induction with 0.2 mM IPTG at 37 C. Cells overproducing a2(103-189) from 6 l of culture were resuspended in 150 ml of T100 buffer (20 mM TrisHCl (pH 8.0) 0.5 mM EDTA, 1 mM benzamidine, 1 mM DTT, 100 mM NaCl), lysed by freeze-thawing and homogenized using an Ultra-Turrax blender device. A cleared extract was prepared by centrifuging the crude extract at 40,000 g and subsequent re-extraction of the pellet with 100 ml of T300 buffer. The cleared extract was applied in a single pass to a 2.5 cm internal diameter Â 8 cm (40 ml) heparin-Sepharose column, and washed with 100 ml of T100, 100 ml of TU100 with 3 M urea, 100 ml of T100 and 100 ml of T200 buffer before elution with a linear gradient of 40 ml of T200 40 ml of T1500. After addition of ammonium sulfate to 1.5 M, the heparin-Sepharose pool was fractionated over a 21.5 mm internal diameter Â 150 mm TSK Phenyl-5PW HPLC column at pH 8.0 (linear gradient from 1050 mM to 300 mM (NH 4 ) 2 SO 4 ). The resulting phenyl pool was dialyzed against 1 mM Hepes (pH 7.5), 0.1 mM EDTA, 0.2 mM DTT, 100 mM NaCl prior to further puri®cation over a 21.5 mm internal diameter Â 150 mm TSK SP-5PW HPLC column at pH 7.5 (linear gradient from 370 mM to 460 mM NaCl). The puri®ed a2(103-189) in the SP pool was dialyzed against 2 mM Hepes (pH 7.5), 0.1 mM EDTA, 0.5 mM DTT, 50 mM NaCl and concentrated against the same buffer by ultra®ltration to a ®nal concentration of 10-30 mg/ml (yields of 15 to 40 mg from 6 l of cells).
Construction of plasmids containing multiple copies of STE2 UAS
The oligonucleotides STO47 (GGGTAAGTACAT GATATCATAAATTTCTAATT) and STO48 (ACCCAA TTAGGAAATTTACATGATATCATGTACTT) were puri®ed by denaturing gel electrophoresis, kinased and annealed prior to self-ligation to create a ladder of fragments. Since STO47 and STO48 anneal to leave complementary but asymmetric sticky ends, the inserts in the ligated fragments should remain in the same orientation. The ligation mixture was treated with Klenow enzyme and fractionated over a 7.5 % polyacrylamide gel. Nucleic acids from bands corresponding to 12 Â , 15Â and 20Â monomers were eluted and ligated into the SmaI site of pUC9. One of the clones obtained from ligat- (Wolberger et al., 1991) . The top half shows the DNA (beige and blue) alone, while the bottom half shows the arrangement of the two protein monomers (red and green). Each complex is arranged in a direct tandem repeat, as signi®ed by the yellow arrows. The sequence of the 21mer fragment is shown. PDB ID code is shown in the lower left. (b) Packing of an integral helical repeat (21 bp) of bent DNA using Watson-Crick base-pairing at the ends as represented by the a1/a2/ DNA complex. The packing of the DNA alone is shown on the left, with a side view of the same in the insert to show that DNA forms a superhelix and not a closed circle. Each complex is arranged in a direct tandem repeat, as visible from the protein arrangement shown on the right (Li et al., 1995b) . (c) Packing of a half-integral helical repeat (26 bp) of bent DNA using Watson-Crick base pairing at the ends as represented by the a2/MCM1/DNA complex (Tan & Richmond, 1998) . The DNA packing on the top half shows a zig-zag arrangement of DNA monomers which form end-to-end packing via the complementary base overhang at either end. Direct tandem repeat of complexes is present here as well, as seen in the arrangement of the MCM1 polypeptide monomer on the DNA shown in the bottom half. The a2 polypeptides have been omitted for clarity. (d) Packing of half-integral helical repeat (27 bp) of bent DNA using G-GC triple stranded ends as represented by the CAP/DNA complex (Schultz et al., 1991) . The two identical DNA strands contain a 13 and 18 base synthetic oligonucleotide, and the protein/DNA complex contains two nicks, signi®ed by a slash in the diagram. Although both strands contain a nominal 31 base oligonucleotide (ignoring the nick), the DNA length is considered to be 30 bp, since the G overhang used for the triple strand pairing does not contribute to DNA length in the crystal. The 3 bp displacement of each DNA monomer with respect to its neighbor causes a loss of 3 bp from the nominal 30 bp, resulting in a 27 bp repeat or 2.5 turns of near B-form DNA arranged in a zig-zag array. The protein/DNA complexes are arranged in a head-to-head, tail-to-tail fashion, as can be seen from the arrangement of CAP monomers with respect to the DNA in the lower half. Both tandem repeats and inverted repeat arrangements are compatible with G-GC triple strand ends. (e) Packing of half-integral helical repeat (18 bp) of bent DNA using C-GC triple stranded ends as represented by the SRF/DNA complex (Pellegrini et al., 1995) . Similar to the CAP/DNA complex, the DNA length is considered to be 18 bp, even though each strand contains 19 bases, since the C overhang used for the triple strand pairing does not contribute to DNA length in the crystal. The 2 bp displacement of each DNA monomer with respect to its neighbor causes a loss of 2 bp from the nominal 18 bp, resulting in a 16 bp repeat or 2.5 turns of near B-form DNA in a zig-zag array. The protein/DNA complexes are arranged in a tandem direct repeat, as can be seen from the arrangement of SRF polypeptide monomers in the lower half. -GC triple strand pairing of boxed region from (g). Note that the triple strand cytosine base must be protonated for these hydrogen bonds to occur. Same color code for hydrogen bonds as in (h).
ing the 12Â monomer band, pST8, contained four copies of the 35mer monomer in tandem head-to-tail repeats. Other clones contained three or fewer copies of tandem repeats.
The 105 bp EcoRV fragment containing three tandem head-to-tail repeats of the 35mer was isolated by partial digestion of pST8 and ligated into the EcoRV site of a pUC9 derivative containing a SalI-EcoRV-XhoI polylinker. One of the resulting clones contained, fortuitously, two tandem copies of the 105 bp EcoRV fragment equivalent to six copies of the 35mer. This insert in this plasmid, pST11, could be``doubled'' by using the compatible SalI and XhoI ends: the EcoRI-XhoI insert fragment containing 6 Â 35mer was ligated with the EcoRI-SalI vector fragment containing 6 Â 35mer to produce pST12 containing 12 copies of the 35mer. This doubling process was repeated twice to yield pST13 with 24 copies of the 35mer, and pST17 with 48 copies of the 35mer. pST13, but not pST17, was apparently stable in the HB101, and stability of pST17 was improved by maintaining in the SURE strain (Stratagene). Attempts to construct plasmids containing 72 or 96 copies of the 35mer yielded plasmids with unstable inserts in both HB101 and SURE strains.
Isolation and purification of STE2 35mer
The STE2 35mer was isolated from either HB101/ pST13 or SURE/pST17 cells using the same procedure, with similar yields (although pST17 contains more insert copies than pST13, the yield of plasmid from SURE cells was lower than HB101 in the single SURE/pST17 preparation performed). A modi®ed version of published procedures by Richmond et al. (1988) , incorporating the use of a higher concentration of acetate using the alkaline lysis procedure (Feliciello & Chinali, 1993) , was used to isolate plasmid DNA from 12 l of culture.
Puri®ed plasmid was digested overnight with EcoRV restriction endonuclease to release the 35mer monomer. Fractionation of the vector from the insert in the digestion mix was achieved by precipitation with 9 % PEG6000 in the presence of the 0.5 M NaCl on ice, followed by centrifugation at 9500 g at 4 C. The 35mer in the supernatant was precipitated by addition of 2.5 volumes of absolute ethanol and incubation at 20 C for 15 minutes. The precipitate was collected by centrifugation at 9000 rpm and 20 C, and resuspended in 20 mM Tris-HCl (pH 7.6) 0.1 mM EDTA, 300 mM NaCl. The 35mer was puri®ed by anion-exchange chromatography over a 21.5 mm internal diameter Â 150 mm TSK DEAE-5PW column at pH 7.6 using a linear gradient from 390 mM to 450 mM NaCl.
The pooled fractions were precipitated by addition of 2.5 volumes of absolute ethanol and MgCl 2 to 10 mM and incubation at 20 C for 15 minutes. The precipitate collected by centrifugation at 9500 g for 20 minutes was resuspended in 10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA to a ®nal concentration of 40 to 50 mg/ml. Preparation of plasmid DNA from 12 l requires one to two days, while puri®cation of STE2 35mer from the plasmid requires two to three additional days.
Purification of oligonucleotides for crystallization
Oligonucleotides synthesized on the 1 mmol scale (Applied Biosystems 380B) were puri®ed by reversedphase HPLC, including detritylation during the single chromatography run. The oligonucleotides were synthesized with the 5 H trityl protecting group left on. After heat deprotection, 100 ml of 1 M Tris base (pH not adjusted) was added to the sample, dried in a Speed Vac and resuspended in 800 ml of 0.1 M TEA-Ac (pH 6.7). The sample was loaded onto a Nucleosil 300-5 C8 reversed-phase HPLC column equilibrated in 15 % CH 3 CN in 0.1 M TEA-Ac (pH 6.7). After the failed synthesis products had eluted, the column was washed with 0.1 M TEA-Ac (pH 6.7). The bound oligonucleotides were detritylated while bound to the column by two injections of 5 ml of 0.5 % (v/v) TFA. The detritylated oligonucleotides were then eluted off the column using a gradient of 10 % to 16 % CH 3 CN for oligonucleotides between 16 and 25 bases long (gradients of 8 % to 14 % or 11.2 % to 17.2 % CH 3 CN was used for 10 to 15mers or 25 to 28mers, respectively). The main eluted peak was pooled, dried in a Speed Vac, resuspended in 300 ml of 1 M NaCl and precipitated by addition of 1 ml of absolute ethanol and centrifugation in a microfuge for ten minutes. The precipitated oligonucleotide was then resuspended in 500 ml of water and lyophilized to dryness before being dissolved in 150 ml of 10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA. Oligonucleotide pairs were annealed together in equimolar ratios by heating to 90 C for three minutes and gradual cooling to room temperature over longer than one hour. MgCl 2 was added to ®nal concentration of 10 mM for annealing of symmetric oligonucleotides to increase the ef®ciency of annealing.
The same procedure was used for oligonucleotides containing iodinated nucleotides (Glen Research; Sterling, VA) except that deprotection was performed for 24 hours at room temperature and samples were kept in the dark wherever possible.
200 HR columns eluted with 10 mM Bis-Tris (pH 7.0), 100 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT at 0.4 ml/ minute. The pooled fractions were concentrated by ultra®ltration against the elution buffer to a ®nal concentration of 10 mg/ml and crystallized in hanging drop against 50 mM sodium acetate (pH 5.5), 100 mM ammonium acetate, 10 mM CaCl 2 , 7-10 % PEG6000 (complex mixed 1:1 (v/v) with reservoir buffer).
